GlassScriptPhysician profile
Erick G Martell
NPI 1649303694
$6,165.61
in general payments reported to CMS, 2019-2025
9 companies · $668 in 2025
The $668 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.44 · 2021: $285 · 2023: $4,368 · 2024: $796 · 2025: $668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,492 · Food and Beverage: $2,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,491.96 |
| Food and Beverage | $2,340.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $5,096.96 | 2023-2025 | |
| Mimedx Group, INC. | $335.50 | 2024-2025 | |
| Allergan, INC. | $284.91 | 2021 | |
| Integra Lifesciences Corporation | $212.84 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Solventum Corporation | $80.52 | 2024 | Prevena, V.A.C.Instill |
| Si-Bone, INC. | $76.66 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $29.78 | 2025 | |
| Mentor Worldwide LLC | $29.54 | 2019 | |
| Next Science LLC | $18.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erick Martell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.